Sarah Cannon Cancer Center Consensus Conference on Novel Developments with Podophyllotoxin Therapy.
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use*; D005047:Etoposide / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D011034:Podophyllotoxin / Q000627:therapeutic use*; D011355:Prodrugs / Q000627:therapeutic use*
D000972:Antineoplastic Agents, Phytogenic; D009943:Organophosphorus Compounds; D011355:Prodrugs; C061400:etoposide phosphate; D005047:Etoposide; D011034:Podophyllotoxin